SCHEMBL367386

SCHEMBL367386

CC(C)(C)OC(=O)n1cccc1O[SiH3]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
BCHE P06276 1/20 0.43
BUB1 O43683 1/20 0.40
PIK3R1 P27986 1/20 0.37
PIK3CA P42336 1/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
GPR119 Q8TDV5 3/20 0.35
TNK2 Q07912 1/20 0.34
HTR6 P50406 1/20 0.33
POLB P06746 1/20 0.33
ABCB1 P08183 1/20 0.33
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ESR2 Q92731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL757849 0.82 HSP90AA1 (0.43) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL10225711 0.81 HSP90AA1 (0.42) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL1442828 0.81 HSP90AA1 (0.42) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL3412038 0.78 HSP90AA1 (0.43) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL15417736 0.77 HSP90AA1 (0.47) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL4916320 0.77 HSP90AA1 (0.47) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL163016 0.77 HSP90AA1 (0.47) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL19547655 0.77 HSP90AA1 (0.40) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL24914436 0.76 HSP90AA1 (0.52) HSP90AA1HSP90AB1BCHEBUB1PIK3R1
SCHEMBL19204908 0.76 HSP90AA1 (0.46) HSP90AA1HSP90AB1BCHEBUB1PIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406239-B1 CYCLIC CARBAMATE COMPOUNDS USEFUL IN ENERGY-CURABLE COMPOSITIONS SUN CHEMICAL BV (NL) 2016-09-14 EP disclosed
US-9428471-B2 Cyclic carbamate compounds useful in energy-curable compositions SUN CHEMICAL B.V. (NL) 2016-08-30 US disclosed
CN-102348696-B Cyclic carbamate compounds useful in energy curable compositions SUN CHEMICAL BV 2015-06-17 CN disclosed
CN-102348696-A Cyclic carbamate compounds useful in energy curable compositions SUN CHEMICAL BV 2012-02-08 CN disclosed
US-20120015159-A1 CYCLIC CARBAMATE COMPOUNDS USEFUL IN ENERGY-CURABLE COMPOSITIONS SUN CHEMICAL B.V. (NL) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015159-A1 CYCLIC CARBAMATE COMPOUNDS USEFUL IN ENERGY-CURABLE COMPOSITIONS ACMSD, PYCARD, DNMT3L HSP90AA1 3021/4885HSP90AB1 3435/4885BCHE 1116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.